We are a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system, or CNS, disorders with limited or no approved treatment options.
$16.00 - $18.00
February 28, 2020
J.P. MORGAN SECURITIES LLC,GOLDMAN SACHS & CO. LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Passage BIO IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277